August 2013 FDA Recall Drug by Teva Pharmaceuticals Usa, Inc.
D-924-2013 - Failed Tablet/Capsule Specification

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa, Inc. on August 6, 2013 for the product Drug. The FDA reported the reason for recall as failed tablet/capsule specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-924-2013

Reason for Recall
Failed Tablet/Capsule Specification: Teva is recalling certain lots of Propanolol HCl Tablets, 10 mg due to the potential of some tablets not conforming to weight specification.
Initiated
08-06-2013
Reported
09-04-2013
Quantity
9003 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA, Inc.
Propranolol Hydrochloride Tablets, USP, 10 mg, Rx Only, 1000 count bottles, Manufactured in Czech Republic by: Teva Czech Industries, sro, Opava komanov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 50111-467-03

Batch or Lot Expiration Information

Lot# : 6A301029, Exp 1/2016; 6A303025, Exp. 3/2016